Robert Wasserman
Stock Analyst at Benchmark
(2.35)
# 2,509
Out of 4,876 analysts
123
Total ratings
42.59%
Success rate
-1.07%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Reiterates: Buy | $75 | $52.80 | +42.05% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $7.90 | +89.87% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $1.69 | +255.03% | 9 | May 12, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $121.87 | +14.88% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $27.46 | +27.48% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $1.11 | +170.27% | 6 | Apr 1, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $3.74 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $52.53 | +42.78% | 9 | Feb 20, 2025 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $135 | $115.72 | +16.67% | 10 | Dec 23, 2024 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $21.48 | +39.66% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $1.42 | +463.38% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $4.24 | +17.92% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $6.83 | +75.70% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.52 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $124.23 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.31 | +3,821.57% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $39.84 | +12.95% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $4.09 | -2.20% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.24 | +1,579.26% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.85 | +3,954.05% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $201.46 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $412.12 | +40.74% | 1 | Jul 16, 2021 |
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $52.80
Upside: +42.05%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.90
Upside: +89.87%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.69
Upside: +255.03%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $121.87
Upside: +14.88%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $27.46
Upside: +27.48%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.11
Upside: +170.27%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.74
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $52.53
Upside: +42.78%
Ligand Pharmaceuticals
Dec 23, 2024
Reiterates: Buy
Price Target: $135
Current: $115.72
Upside: +16.67%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $21.48
Upside: +39.66%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.42
Upside: +463.38%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $4.24
Upside: +17.92%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $6.83
Upside: +75.70%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.52
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $124.23
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.31
Upside: +3,821.57%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $39.84
Upside: +12.95%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $4.09
Upside: -2.20%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.24
Upside: +1,579.26%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.85
Upside: +3,954.05%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $201.46
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $412.12
Upside: +40.74%